Expression of biomarkers modulating prostate cancer angiogenesis: Differential expression of annexin II in prostate carcinomas from India and USA

被引:43
作者
Abhijit G Banerjee
Jie Liu
Yawei Yuan
Velliyur K Gopalakrishnan
Sonny L Johansson
Amit K Dinda
Narmada P Gupta
Lindsey Trevino
Jamboor K Vishwanatha
机构
[1] Department of Biochemistry, Univ. of Nebraska Medical Center, Omaha
[2] Department of Pathology/Microbiology, Univ. of Nebraska Medical Center, Omaha
[3] UNMC Eppley Cancer Center, Univ. of Nebraska Medical Center, Omaha
[4] Department of Pathology, All India Inst. of Medical Sciences, New Delhi
[5] Department of Urology, All India Inst. of Medical Sciences, New Delhi
[6] St. Mary's University, San Antonio
关键词
Prostate Cancer; LNCaP Cell; Ethylene Diamine Tetraacetic Acid; Ethylene Diamine Tetraacetic Acid; Prostate Epithelial Cell;
D O I
10.1186/1476-4598-2-34
中图分类号
学科分类号
摘要
Background: Prostate cancer (PCa) incidences vary with genetic, geographical and ethnic dietary background of patients while angiogenesis is modulated through exquisite interplay of tumor-stromal interactions of biological macromolecules. We hypothesized that comprehensive analysis of four biomarkers modulating angiogenesis in PCa progression in two diverse populations might explain the variance in the incidence rates. Results: Immunohistochemical analysis of 42 PCa biopsies reveals that though Anx-II expression is lost in both the Indian and American population with Gleason scores (GS) ranging between 6 and 10, up to 25 % of cells in the entire high grade (GS > 8) PD PCa samples from US show intense focal membrane staining for Anx-II unlike similarly graded specimens from India. Consistent with this observation, the prostate cancer cell lines PC-3, DU-145 and MDA PCa 2A, but not LNCaP-R, LNCAP-UR or MDA PCa 2B cell lines, express Anx-II. Transcriptional reactivation of Anx-II gene with Aza-dC could not entirely account for loss of Anx-II protein in primary PCa. Cyclooxygenase-2 (COX-2) was moderately expressed in most of high grade PIN and some MD PCa and surrounding stroma. COX-2 was not expressed in PD PCa (GS ∼7-10), while adjacent smooth muscles cells stained weakly positive. Decorin expression was observed only in high grade PIN but not in any of the prostate cancers, atrophy or BPH while stromal areas of BPH stained intensively for DCN and decreased with advancing stages of PCa. Versican expression was weak in most of the MD PCa, moderate in all of BPH, moderately focal in PD PC, weak and focal in PIN, atrophy and adjacent stroma. Conclusions: Expression of pro- and anti-angiogenic modulators changes with stage of PCa but correlates with angiogenic status. Focal membrane staining of Anx-II reappears in high grade PCa specimens only from US indicating differential expression of Anx-II. COX-2 stained stronger in American specimens compared to Indian specimens. The sequential expression of DCN and VCN in progressive stages was similar in specimens from India and USA indicating no population-based differences. The mechanistic and regulatory role of Anx-II in PCa progression warrants further investigation. © 2003 Banerjee et al; licensee BioMed Central Ltd.
引用
收藏
页数:13
相关论文
共 45 条
[1]  
Quinn M., Babb P., Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: International comparisons, BJU Int., 90, pp. 162-173, (2002)
[2]  
Srinivas V., Mehta H., Amin A., Choudary R., Gadgil N., Ravishanker D., Phadke A.G., Carcinoma of the prostate - State at initial presentation, Int. Urol. Nephrol., 27, pp. 419-422, (1995)
[3]  
Desai S.B., Borges A.M., The prevalence of high-grade prostatic intraepithelial neoplasia in surgical resection specimens: An Indian experience, Cancer, 94, pp. 2350-2352, (2002)
[4]  
Weidner N., Carroll P.R., Flax J., Blumenfeld W., Folkman J., Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma, Am. J. Pathol., 143, pp. 401-409, (1993)
[5]  
Shih S.C., Robinson G.S., Perruzzi C.A., Calvo A., Desai K., Green J.E., Ali I.U., Smith L.E., Senger D.R., Molecular profiling of angiogenesis markers, Am. J. Pathol., 161, pp. 35-41, (2002)
[6]  
Doll J.A., Reiher F.K., Crawford S.E., Pins M.R., Campbell S.C., Bouck N.P., Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate, Prostate, 49, pp. 293-305, (2001)
[7]  
Ferrer F.A., Miller L.J., Andrawis R.I., Kurtzman S.H., Albertsen P.C., Laudone V.P., Kreutzer D.L., Angiogenesis and prostate cancer: In vivo and in vitro expression of angiogenesis factors by prostate cancer cells, Urology, 51, pp. 161-167, (1998)
[8]  
Lutsenko S.V., Kiselev S.M., Severin S.E., Molecular mechanisms of tumor angiogenesis, Biochemistry (Mosc.), 68, pp. 286-300, (2003)
[9]  
Liao Z., Boileau T.W., Erdman J.W., Clinton S.K., Interrelationships among angiogenesis, proliferation, and apoptosis in the tumor microenvironment during N-methyl-N-nitrosourea androgen-induced prostate carcinogenesis in rats, Carcinogenesis, 23, pp. 1701-1711, (2002)
[10]  
Tuxhorn J.A., Ayala G.E., Rowley D.R., Reactive stroma in prostate cancer progression, J. Urol., 166, pp. 2472-2483, (2001)